{
  "id": 5366,
  "text": "Int J Gynaecol Obstet 2012;117:23-26.Available at: http://www.ncbi.nlm.nih.gov/pubmed/22265255.185.Eddy GL, Bundy BN, Creasman WT, et al.Treatment of (\"bulky\") stage IB cervical cancer with or without neoadjuvant vincristine and cisplatin prior to radical hysterectomy and pelvic/para-aortic lymphadenectomy: a phase III trial of the gynecologic oncology group.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: Int J Gynaecol Obstet 2012;117:23-26.Available at: http://www.ncbi.nlm.nih.gov/pubmed/22265255.185.Eddy GL, Bundy BN, Creasman WT, et al.Treatment of (\"bulky\") stage IB cervical cancer with or without neoadjuvant vincristine and cisplatin prior to radical hysterectomy and pelvic/para-aortic lymphadenectomy: a phase III trial of the gynecologic oncology group.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "根据请求，回复为：SKIP",
  "query": "根据提供的文本：  \n**问题**: \"什么是新辅助化疗联合手术治疗体积较大IB期宫颈癌的疗效及试验设计？\"",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 根据提供的文本：  \n**问题**: \"什么是新辅助化疗联合手术治疗体积较大IB期宫颈癌的疗效及试验设计？\"\n\n<reference text>: Int J Gynaecol Obstet 2012;117:23-26.Available at: http://www.ncbi.nlm.nih.gov/pubmed/22265255.185.Eddy GL, Bundy BN, Creasman WT, et al.Treatment of (\"bulky\") stage IB cervical cancer with or without neoadjuvant vincristine and cisplatin prior to radical hysterectomy and pelvic/para-aortic lymphadenectomy: a phase III trial of the gynecologic oncology group.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "根据请求，回复为：SKIP"
}